UCB Pharma
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UCB Pharma, covering 2012-06-14 to 2012-06-14. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA) [Phase 3]